Interim Condensed Consolidated Statements of Cash Flow - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net loss for the period	$ (33,127)	$ (25,184)
Items not affecting cash:
Stock based compensation	965	779
Inventory net realizable value adjustments	2,061	8,158
Amortization of mineral properties	205	828
Depreciation of capital assets	1,979	1,546
Accretion expense	518	371
Amortization of deferred loan costs	33	33
Provision for reclamation	(6)	0
Warrant liability revaluation loss (gain)	(4,442)	4,155
Gain on sale of capital assets	(2)	0
Foreign exchange gain	(22)	(329)
Changes in non-cash working capital:
Trade receivables	(27)	5,600
Lease receivable	(520)	0
Inventory	(3,736)	(2,956)
Prepaid expenses	623	(565)
Accounts payable and accrued liabilities	3,011	2,105
Cash provided by used in operating activities	(32,487)	(16,659)
Investing activities
Purchase of capital assets	(5,701)	(1,923)
Cash provided by used in investing activities	(5,701)	(1,923)
Financing activities
Issuance of common shares for cash	97,568	46,637
Share issue costs	4,683	(3,002)
Proceeds from exercise of warrants and stock options	12,228	969
RSUs redeemed for cash	(56)	(81)
Repayment of debt	(5,727)	(4,027)
Cash provided by used in financing activities	99,330	40,496
Effects of foreign exchange rate changes on cash	(34)	7
Increase in cash, cash equivalents, and restricted cash and cash equivalents	61,108	21,921
Beginning cash, cash equivalents, and restricted cash and cash equivalents	68,249	41,140
Ending cash, cash equivalents, and restricted cash and cash equivalents	$ 129,357	$ 63,061